Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05869968 · ClinicalTrials.gov registry record
SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI
A clinical trial of Spinal Cord Injuries and Healthy (Controls), sponsored by Northwell Health.
- Recruiting
- Registry status
- 140
- Enrollment target
- 1
- Study location
NCT05869968: Recruiting study of Spinal Cord Injuries and Healthy (Controls), sponsored by Northwell Health.
NCT05869968 is a study of Spinal Cord Injuries and Healthy (Controls) that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 140 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (130% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05869968, a study of Spinal Cord Injuries and Healthy (Controls), is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational research study is to better understand immune responses to vaccines against viruses (influenza or SARS-CoV2). The goal is to determine any differences in immune responses to vaccines in uninjured people and in people living with spinal cord injuries, who are typically at increased risk of infections.
Primary Outcome
Serum samples will be used to determine if gene expression levels made by specific types of white blood cells are different between participant groups and within the SCI group by injury level and severity.
Conditions Studied
Study Locations (1)
New York
- Northwell Health - Manhasset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2023-03-31 |
| Est. Completion | 2027-12-31 |
What NCT05869968 shows while recruiting
NCT05869968 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (130% higher).
The record links to 5 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 0 interventions.
NCT05869968 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05869968 about?
NCT05869968 is a clinical study titled "SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI". The purpose of this observational research study is to better understand immune responses to vaccines against viruses (influenza or SARS-CoV2). The goal is to determine any differences in immune responses to vaccines in uninjured people and in people living with spinal cord injuries, who are typical...
What is the current status of trial NCT05869968?
This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2023-03-31. Estimated completion is 2027-12-31.
What conditions does trial NCT05869968 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Healthy (Controls), COVID-19 Vaccine, Traumatic Spinal Cord Injury, Flu Vaccine.
Who is sponsoring clinical trial NCT05869968?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05869968 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05869968's enrollment target sits among peer trials
140 21st of 202 higher than 181 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Effectiveness of the Collaborative Community Clinic for Persons With Spinal Cord Injury and Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy